Loading...
•
Jun 30, 2022
Enfusion Q2 2022 Earnings Report
Revenue increased due to new client signings and growth from current clients.
Key Takeaways
Enfusion announced strong Q2 2022 results, exceeding revenue and profitability expectations. Total revenue grew by 38% year-over-year, driven by new client signings and growth from existing clients. The company signed larger deals and added nine institutional asset managers, demonstrating its growing impact on larger funds globally.
Revenue grew 38% Y-o-Y reflecting consistent execution and strong client demand
Exceeded Adjusted EBITDA guidance and generated positive operating cash flow
Conversions represented 75% of new client bookings; bookings for new client conversions up 63% Y-o-Y
Net Dollar Retention expanded to 121.9%
Enfusion
Enfusion
Forward Guidance
Enfusion provided guidance for Q3 and full year 2022.
Positive Outlook
- Third Quarter 2022 Total revenue is expected to be in the range of $38 million to $39 million.
- Third Quarter 2022 Adjusted EBITDA is expected to be in the range of $5.0 million to $5.5 million.
- Full Year 2022 Total revenue is expected to be in the range of $149.3 million to $152.3 million.
- Full Year 2022 Adjusted EBITDA is expected to be in the range of $18.2 million to $20.2 million.